Caspase Inhibitors: A Pharmaceutical Industry Perspective

E-ISSN： 1873-4294|5|16|1697-1717

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.5, Iss.16, 2005-12, pp. : 1697-1717

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Challenges in Pediatric Drug Development: A Pharmaceutical Industry Perspective

By Rose Klaus

Pediatric Drugs, Vol. 11, Iss. 1, 2009-01 ,pp. : 57-59

Adis International

Access to resources Recommend Favorite

Pharmacoeconomics in the New Millennium: A Pharmaceutical Industry Perspective

By Thwaites R.

PharmacoEconomics, Vol. 13, Iss. 2, 1998-02 ,pp. : 175-180

Adis International

Access to resources Recommend Favorite

Radiopharmaceuticals for Oncology Drug Development: A Pharmaceutical Industry Perspective

Current Pharmaceutical Design, Vol. 15, Iss. 9, 2009-03 ,pp. : 957-965

Bentham Science Publishers

Access to resources Recommend Favorite

NICE Guide to the Methods of Technology Appraisal: Pharmaceutical Industry Perspective

By Earnshaw Julia

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 725-727

Adis International

Access to resources Recommend Favorite

Pharmaceutical industry perspective on risk evaluation and mitigation strategies: manufacturer take heed

By Nicholson Susan Peterson Janet Yektashenas Behin

Expert Opinion on Drug Safety, Vol. 11, Iss. 2, 2012-03 ,pp. : 299-314

Informa Healthcare

Access to resources Recommend Favorite